Radiation Proctitis Market

1. HBOT, IV Vitamin Drops to Boost Patient Immunity amid COVID-19 Pandemic Healthcare facilities such as the Hyperbaric Medical Solutions is taking extra preventive steps to mitigate the risks of the coronavirus pandemic to ensure all patients are offered clean and safe environments. Stakeholders in the radiation proctitis market are increasing efforts to boost the availability for hyperbaric oxygen therapy (HBOT), which is being associated with enhancing the immune system in the wake of the COVID-19 outbreak. Report market.html Overview: https://www.transparencymarketresearch.com/radiation-proctitis- Companies in the radiation proctitis market are maintaining steady supply of intravenous (IV) vitamin drips, which help to strengthen the immunity of patients and help in detoxification. However, a slowdown in the global economy may have affected revenue collections in healthcare facilities. Hence, healthcare companies should adopt flexible business strategies, and team up with their stakeholders in the value chain to manage investments and product launches. Request a sample to get extensive insights into the Radiation Proctitis Market Alternative Trials Design Help Overcome Uncertainties in Controlled Trials for HBOT HBOT is emerging as the gold standard for treating radiation toxicity. However, this treatment is being associated with side effects such as transient myopia, fatigue, and barotrauma. Moreover, patients with severe complaints refrain from participating and even opt out of randomized controlled trials. Hence, companies in the radiation proctitis market are collaborating with research institutes to create alternative trials design in order to overcome the issues in trials within cohorts design. The approval of the U.S.-based FDA (Food & Drug Association) for HBOT is creating incremental opportunities for companies in the radiation proctitis market. This explains why the market is expected to reach US$ 748.5 Mn by 2030. To understand how our report can bring difference to your business strategy, Ask for a brochure Topical Corticosteroids, Antidiarrheal Therapies Improve Medical Outcomes

2. Improvements in radiotherapy techniques are enabling superior delivery of radiation doses, and have the potential to easily reduce cases of both chronic and acute proctitis. Despite these advancements, the radiation proctitis market is projected to register a favorable CAGR of ~7% during the assessment period, owing to a high prevalence of radiation toxicity. Healthcare providers in the radiation proctitis market are gaining proficiency iron substitution therapies. Manufacturers are boosting their output capacities in topical corticosteroids, sucralfate injections, and increasing R&D in antidiarrheal therapies, since the latter is gaining popularity as an aggressive means for patient care. Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=81551 Intraperitoneal Injections, Colostomy Translate into Growth Opportunities for Healthcare Providers Apart from oral therapies, companies and healthcare providers in the radiation proctitis market are offering remedial laser techniques in cases of continuous rectal bleeding. Clinicians are attempting formaldehyde administration before the surgical therapy. Healthcare professionals are conducting a descending or transverse colostomy for patients when surgery is required. Companies in the radiation proctitis market are increasing the availability of intraperitoneal injections of formalin. Novel methods of cold therapy and radiofrequency ablation (RFA) are grabbing the attention of healthcare providers. Colostomy is gaining prominence as an effective and safe procedure for treating rectal ulcer of chronic radiation proctitis patients. Colostomy helps to control rectal bleeding and effectively relieve pain in patients. Prostaglandins Aid in Healing of Inflammation, Wounds in Prostate Cancer Patients The high prevalence of hemorrhagic radiation proctitis is acting as a key driver for the expansion of the radiation proctitis market. However, the lack of consensus for the management of hemorrhagic radiation proctitis is likely to inhibit market growth. Despite the challenges, clinicians are adopting rectal resection as an available option for hemorrhagic radiation proctitis management. Healthcare companies in the radiation proctitis market are increasing their R&D in prostaglandins that aid in the healing of inflammation and wounds. This has led to the popularity of misoprostol, which is found to be efficacious in treating complications that arise in patients with prostate cancer that receive radiation

3. therapy. Misoprostol rectal suppositories are being highly publicized for reducing the complications associated with acute and chronic radiation proctitis. Stuck in a neck-to-neck competition with other brands? Request a custom report on Radiation Proctitis Market Analysts’ Viewpoint Healthcare providers are providing uncompromised care services to radiation proctitis patients despite reduced hospital and clinical visits during the ongoing COVID-19 outbreak. Even as the National Comprehensive Cancer Network (NCCN) is setting guidelines for the Radiation Therapy Compendium™ Development, companies and healthcare providers are increasing efforts to gain proficiency in HBOT. However, HBOT is associated with oxygen toxicity and seizures. Hence, companies and healthcare professionals in theradiation proctitis marketshould encourage patients to participate in controlled trials and alternative trial design to improve medical outcomes. As such, manufacturers are increasing their focus in stool softeners and treatments that heal tissues in order to minimize patient complications. Radiation Proctitis Market: Overview According to Transparency Market Research’s latest report on the global radiation proctitis market for the historical period 2018–2019 and forecast period 2020–2030, surge in adoption of advanced technologies to treat cancer is projected to boost the growth of the global market Radiation proctitis is inflammation of the rectum due to exposure of X rays or other ionizing radiation. The management of radiation proctitis is divided into invasive and non-invasive treatment. Non-invasive treatment includes anti- inflammatory agents, sucralfate, short-chain fatty acids, hyperbaric, and antioxidants. Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id= 81551 Rise in Prevalence of Cancer to Drive Radiation Proctitis Market Increase in incidence of prostate cancer, owing to genetic alterations & family history drives the demand for advanced therapy, which, in turn, boosts the growth of the global radiation proctitis market. Prostate cancer is the second most frequently diagnosed cancer in men and the fifth leading cause of death globally. The incidence of anal cancer has increased significantly in the last

4. decade, and is currently estimated to be ~1.5 per 100,000 in the general population of the U.S., particularly in certain population subgroups. Increase in Adoption of Radiation Therapy to Treat Cancer to Propel Radiation Proctitis Market Over 14 million new cases of cancer are diagnosed globally each year. Radiation therapy (RT) has the potential to improve the rates of cure of 3.5 million people and provide palliative relief for an additional 3.5 million people. Radiotherapy is the most commonly use treatment for cancer regimen in countries in the West. Technological advancements with a better understanding of tumor biology at the molecular, cellular, physiological, and immunological levels have improved the treatment efficacy of radiotherapy. This is anticipated to drive the adoption of radiation therapy, which is expected to boost the global radiation proctitis market. High Cost of Hyperbaric Oxygen Therapy to Hamper Radiation Proctitis Market Cost is one of the major factors that influences the selection of treatment. Hyperbaric oxygen therapy is one of the few treatments for patients with severe radiation-induced symptoms, which include proctitis and cystitis with bleeding. Currently, hyperbaric oxygen therapy is expensive and therefore, the economically weak cannot afford it, despite the significant therapeutic effects. This acts as a major restraint of the global radiation proctitis market. Radiation Proctitis Market: Competition Landscape This report profiles major players operating in the global radiation proctitis market based on various attributes and recent developments The global radiation proctitis market is highly fragmented, with the presence of a large number of global as well as regional players Leading players operating in the global radiation proctitis market include oAllergan plc oTeva Pharmaceutical Industries Ltd. oAmneal Pharmaceuticals, Inc. oPfizer, Inc. oMylan, Inc. (Viatris) oSanofi oJohnson & Johnson (Johnson & Johnson Consumer, Inc.) oSun Pharmaceutical Industries Ltd.

5. oEnvironmental Tectonics Corporation oSechrist Industries, Inc. About Transparency Market Research Transparency Market Research registered at Wilmington, Delaware, United States, is a global market research company providing custom research and consulting services. TMR provides in-depth insights into factors governing demand in the market. It divulges opportunities across various segments based on Source, Application, Sales Channel, and End- Use that will favor growth in the market over the next 9 years. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ Contact Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email:sales@transparencymarketresearch.com